维普中文期刊产品整合服务

Lysine succinylation,the metabolic bridge between cancer and immunity

查看全文 作  者:Rui [1]Shen;Hongyun [2]Ruan;Shuye [2]Lin;Bin [2]Liu;Hang [1,3]Song;Lu [1,3]Li;Teng [2]Ma 高影响力作者 机构地区:[1]School of Integrated Chinese and Western Medicine,Anhui University of Chinese Medicine,Hefei,Anhui 230012,China;[2]Cancer Research Centre,Beijing Chest Hospital,Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute,Beijing 101149,China;[3]Department of Biochemistry and Molecular Biology,School of Integrated Chinese and Western Medicine,Anhui University of Chinese Medicine,Hefei,Anhui 230012,China高影响力机构 出  处:《Genes & Diseases》索引2023年第10卷第6期,共9页高影响力期刊 基  金:supported by Youth Wan Jiang Scholar of Anhui Province,China(No.DT2100001172);Beijing Xisike Clinical Oncology Research Foundation(China)(No.Y-HR2020MS-0156). 摘  要:Lysine succinylation is a naturally occurring post-translational modification(PTM)that regulates the stability and function of proteins.It can be regulated by enzymes such as SIRT5 and SIRT7.Recently,the effect and significance of lysine succinylation in cancer and its implication in immunity have been extensively explored.Lysine succinylation is involved in the malignant phenotype of cancer cells.Abnormal regulation of lysine succinylation occurs in different cancers,and inhibitors targeting lysine succinylation regulatory enzymes can be used as potential anti-cancer strategies.Therefore,this review focused on the target protein lysine succinylation and its functions in cancer and immunity,in order to provide a reference for finding more potential clinical cancer targets in the future. 关 键 词:IMMUNITY MITOCHONDRIA SIRT5 Succinyl-CoA SUCCINYLATION
相关文献

参考文献(66)

引证文献(1)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费